• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

注意缺陷多动障碍的最新进展。

Update on attention-deficit/hyperactivity disorder.

作者信息

Daley Katie Campbell

机构信息

Department of Medicine, Children's Hospital Boston, Boston, Massachusetts 02115, USA.

出版信息

Curr Opin Pediatr. 2004 Apr;16(2):217-26. doi: 10.1097/00008480-200404000-00020.

DOI:10.1097/00008480-200404000-00020
PMID:15021207
Abstract

PURPOSE OF REVIEW

Attention-deficit/hyperactivity disorder (ADHD) is present in 3% to 10% of children in the United States. Children with ADHD can have academic impairments, social dysfunction, and poor self-esteem. There is also a higher risk of both cigarette smoking and substance abuse. Given this, the importance of treatment for ADHD needs to be underscored. This article will briefly review the diagnosis, etiology, and treatment of ADHD, with particular focus on nonstimulant medication and alternative treatment modalities.

RECENT FINDINGS

Recent evidence suggests that the overall rate of medication treatment for ADHD has been increasing, with over 2 million children being treated with stimulants in 1997. With this increase, controversy has arisen over the possible association of stimulants with growth suppression. In addition, estimates indicate that as many as 30% of children with ADHD either do not respond to stimulant treatment or cannot tolerate the treatment secondary to side effects. This has lead to the consideration of treatment with both nonstimulant medications as well as alternative therapies, including diet, iron supplementation, herbal medications, and neurofeedback. Considering the various treatment options now available for ADHD, along with the complexity of the condition, clinical practice guidelines are emerging for the treatment of ADHD and will be discussed.

SUMMARY

ADHD continues to be a serious health problem. Adequate treatment is needed to avoid academic impairments, social dysfunction, and poor self-esteem. This treatment includes consideration of stimulant medication, nonstimulant medication, as well as alternative therapies. The child with ADHD is likely better served with a mutimodal treatment plan, including medication, parent/school counseling, and behavioral therapy. Implementing an evidenced based algorithm for the treatment of ADHD may prove to be most effective.

摘要

综述目的

注意缺陷多动障碍(ADHD)在美国3%至10%的儿童中存在。患有ADHD的儿童可能有学业障碍、社交功能障碍和自尊心低下的问题。吸烟和药物滥用的风险也更高。鉴于此,需要强调ADHD治疗的重要性。本文将简要回顾ADHD的诊断、病因和治疗,特别关注非兴奋剂药物和替代治疗方式。

最新发现

最近的证据表明,ADHD药物治疗的总体比例一直在上升,1997年有超过200万儿童接受兴奋剂治疗。随着这一比例的上升,关于兴奋剂与生长抑制之间可能存在的关联引发了争议。此外,据估计,多达30%的ADHD儿童对兴奋剂治疗无反应或因副作用无法耐受该治疗。这导致了对非兴奋剂药物以及替代疗法的考虑,包括饮食、铁补充剂、草药和神经反馈。考虑到目前可用于ADHD的各种治疗选择以及该病症的复杂性,ADHD治疗的临床实践指南正在形成并将进行讨论。

总结

ADHD仍然是一个严重的健康问题。需要进行充分治疗以避免学业障碍、社交功能障碍和自尊心低下。这种治疗包括考虑使用兴奋剂药物、非兴奋剂药物以及替代疗法。患有ADHD的儿童可能通过多模式治疗计划得到更好的治疗,包括药物治疗、家长/学校咨询和行为治疗。实施基于证据的ADHD治疗算法可能被证明是最有效的。

相似文献

1
Update on attention-deficit/hyperactivity disorder.注意缺陷多动障碍的最新进展。
Curr Opin Pediatr. 2004 Apr;16(2):217-26. doi: 10.1097/00008480-200404000-00020.
2
Low dopamine function in attention deficit/hyperactivity disorder: should genotyping signify early diagnosis in children?注意缺陷多动障碍中多巴胺功能低下:基因分型是否预示着儿童的早期诊断?
Postgrad Med. 2014 Jan;126(1):153-77. doi: 10.3810/pgm.2014.01.2735.
3
A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.一个就注意力缺陷/多动障碍的诊断和管理达成社区共识的过程。
Pediatrics. 2005 Jan;115(1):e97-104. doi: 10.1542/peds.2004-0953.
4
Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.儿童及青少年注意力缺陷/多动障碍的诊断与治疗。美国医学协会科学事务委员会。
JAMA. 1998 Apr 8;279(14):1100-7. doi: 10.1001/jama.279.14.1100.
5
Attention-deficit/hyperactivity disorder.注意力缺陷多动障碍
Adv Pediatr. 1997;44:331-67.
6
Attention-deficit-hyperactivity disorder: an update.注意缺陷多动障碍:最新进展
Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656.
7
Pharmacotherapy of attention-deficit/hyperactivity disorder: nonstimulant medication approaches.注意缺陷/多动障碍的药物治疗:非兴奋剂药物治疗方法
Expert Rev Neurother. 2007 Feb;7(2):195-201. doi: 10.1586/14737175.7.2.195.
8
Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder.患有注意力缺陷/多动障碍的儿童群体中精神药物的使用情况。
Pediatrics. 2002 May;109(5):733-9. doi: 10.1542/peds.109.5.733.
9
Alternative (nonstimulant) medications in the treatment of attention-deficit/hyperactivity disorder in children.
Pediatr Clin North Am. 1999 Oct;46(5):965-75. doi: 10.1016/s0031-3955(05)70166-8.
10
Attention-deficit/hyperactivity disorder and substance abuse.注意缺陷多动障碍与物质滥用。
Pediatrics. 2014 Jul;134(1):e293-301. doi: 10.1542/peds.2014-0992.

引用本文的文献

1
Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.多不饱和脂肪酸(PUFA)治疗儿童和青少年注意缺陷多动障碍(ADHD)。
Cochrane Database Syst Rev. 2023 Apr 14;4(4):CD007986. doi: 10.1002/14651858.CD007986.pub3.
2
A Randomized Trial of Comparing the Efficacy of Two Neurofeedback Protocols for Treatment of Clinical and Cognitive Symptoms of ADHD: Theta Suppression/Beta Enhancement and Theta Suppression/Alpha Enhancement.比较两种神经反馈方案治疗多动症临床和认知症状疗效的随机试验:θ波抑制/β波增强与θ波抑制/α波增强
Biomed Res Int. 2017;2017:3513281. doi: 10.1155/2017/3513281. Epub 2017 Feb 9.
3
Attention-deficit/hyperactivity disorder Under Treatment Outcomes Research (AUTOR): a European observational study in pediatric subjects.
注意缺陷/多动障碍治疗效果研究(AUTOR):一项针对儿科受试者的欧洲观察性研究。
Atten Defic Hyperact Disord. 2015 Dec;7(4):295-311. doi: 10.1007/s12402-015-0177-y. Epub 2015 Jun 27.
4
Integration of an EEG biomarker with a clinician's ADHD evaluation.脑电图生物标志物与临床医生对注意力缺陷多动障碍评估的整合。
Brain Behav. 2015 Apr;5(4):e00330. doi: 10.1002/brb3.330. Epub 2015 Mar 5.
5
Self-reported efficacy of neurofeedback treatment in a clinical randomized controlled study of ADHD children and adolescents.自我报告的神经反馈治疗在 ADHD 儿童和青少年的临床随机对照研究中的疗效。
Neuropsychiatr Dis Treat. 2014 Sep 2;10:1645-54. doi: 10.2147/NDT.S66466. eCollection 2014.
6
Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.用于治疗儿童和青少年注意力缺陷多动障碍(ADHD)的多不饱和脂肪酸(PUFA)
Cochrane Database Syst Rev. 2012 Jul 11;2012(7):CD007986. doi: 10.1002/14651858.CD007986.pub2.
7
A new rating scale for adult ADHD based on the Symptom Checklist 90 (SCL-90-R).基于症状清单 90(SCL-90-R)的成人 ADHD 新评分量表。
Eur Arch Psychiatry Clin Neurosci. 2012 Sep;262(6):519-28. doi: 10.1007/s00406-011-0288-1. Epub 2012 Jan 3.
8
Treatment for ADHD: is more complex treatment cost-effective for more complex cases?注意力缺陷多动障碍的治疗:对于更复杂的病例,更复杂的治疗是否具有成本效益?
Health Serv Res. 2007 Feb;42(1 Pt 1):165-82. doi: 10.1111/j.1475-6773.2006.00599.x.
9
Impact of methylphenidate formulation on treatment patterns and hospitalizations: a retrospective analysis.哌甲酯制剂对治疗模式和住院情况的影响:一项回顾性分析。
Ann Gen Psychiatry. 2006 Apr 10;5:5. doi: 10.1186/1744-859X-5-5.
10
Substance abuse in patients with attention-deficit hyperactivity disorder : therapeutic implications.注意缺陷多动障碍患者的物质滥用:治疗意义
CNS Drugs. 2005;19(8):643-55. doi: 10.2165/00023210-200519080-00001.